18 June 2002
Cyclic nitric oxide release by human granulocytes, and invertebrate gangliaand immunocytes: nano-technological enhancement of amperometric nitric oxide determination.
George B Stefano, Harold I Magazine, Michel SalzetMed Sci Monit 2002; 8(6): BR199-204 :: ID: 420824
Abstract
BACKGROUND: Various tissues from vertebrates and invertebrates respondto external signal molecules by rapid release of nitric oxide (NO) mediated by constitutive nitric oxidesynthase.MATERIAL/METHODS: Invertebrate immunocytes were collected from maintained stock and human granulocyteswere isolated from leukocyte-enriched blood obtained from the Long Island Blood Services. The invertebrateganglionic tissue was either extracted or exposed for ex vivo and in vivo evaluation. Nitric oxide releasewas measured using a newly developed NO-selective nanoprobe, exhibiting enhanced sensitivity.RESULTS:Evaluation of NO release from the pedal ganglia of the marine bivalve, Mytilus edulis, demonstrated invitro release of NO that fluctuated from 969 to 1003 pM, with a mean change in NO of 35 pM/cycle anda mean cycle time of approximately 4 minutes. Basal release of NO/cycle from the ganglia in vivo wasincreased significantly to approximately 65 pM (P<0.05) with an increase in cycle time to approximately 7 minutes. Exposure of the ganglia to morphine in vivo resulted in a significant increase in NO release and a lack of NO pulsations. The fluctuation in NO release from immunocytes of Mytilus edulis was approximately 27 pM per cycle with a cycle time of 4 minutes whereas human granulocytes release fluctuated approximately 23 pM with a cycle time of 6 minutes.
Conclusions: These data demonstrate that basal release of NO from various tissues is released in a cyclic manner and the cycle time and magnitude is subject to regulation by external stimuli.
Keywords: Electrochemistry, Ganglia, Granulocytes, Immune System, Mussels, Nitric Oxide, Research Support, U.S. Gov
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
17 Mar 2024 : Clinical Research
Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among ...Med Sci Monit In Press; DOI: 10.12659/MSM.942667
27 Mar 2024 : Clinical Research
Impact of Patient Education Formats on Treatment Adherence and Denture Hygiene in Edentulous Patients: A Co...Med Sci Monit In Press; DOI: 10.12659/MSM.944175
27 Mar 2024 : Clinical Research
Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.944114
15 May 2024 : Database Analysis
MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOBMed Sci Monit In Press; DOI: 10.12659/MSM.944685
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952